Histopathologic types of benign breast lesions and the risk of breast cancer: Case-control study

American Journal of Surgical Pathology

Volumn 26, Issue 4, 2002, Pages 421-430

  Shaaban, A M ^a   Sloane, J P ^a   West, C R ^a   Moore, F R ^a   Jarvis, C ^a   Williams, E M I ^a   Foster, Christopher S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Benign breast lesions; Breast cancer; Relative risk

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DISEASE; BREAST DUCT; BREAST HYPERPLASIA; CANCER MODEL; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MORPHOLOGY; PROBABILITY; RISK FACTOR; STATISTICAL ANALYSIS;

AGE FACTORS; BREAST DISEASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FOLLOW-UP STUDIES; RISK FACTORS;

EID: 0036209289     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200204000-00003     Document Type: Article

References (40)

1. Histopathology of benign nonpalpable breast lesions identified by mammography
2. Prognostic significance of benign proliferative breast disease
3. A prospective study of the development of breast cancer in 16,692 women with benign breast disease
4. Intraductal papillary tumors of the breast: A study of 78 cases
5. Cystic disease of the breast: Relationship to carcinoma
6. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland free mammary fat pads of female C3H mice
7. Risk factors for breast cancer in women with proliferative breast disease
8. Long-term risk of breast cancer in women with fibroadenoma
9. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast: European Commission Working Group on Breast Screening Pathology
10. Columnar alteration with prominent apical snouts and secretions: A spectrum of changes frequently present in breast biopsies performed for microcalcifications
11. Sources of uncertainty in interpretation of breast biopsies
12. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: A lesion associated with tubular carcinoma
13. Radial scars in benign breast-biopsy specimens and the risk of breast cancer
14. Invasive breast cancer risk in women with sclerosing adenosis
15. Relationship of fibrocystic disease to carcinoma of the breast
16. Atypical epithelial hyperplasia associated with breast cancer and fibrocystic disease
17. Chronic mastopathy and breast cancer: A follow-up study
18. A prospective study of benign breast disease and the risk of breast cancer
19. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types
20. Histologic types of benign breast disease and the risk for breast cancer: The Cancer and Steroid Hormone Study Group
21. Report: Registration of cancer diagnosed in 1993-1996, England and Wales
22. Atypical cystic lobules: An early stage in the formation of low-grade ductal carcinoma in situ
23. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia
24. Relation between component parts of fibrocystic disease complex and breast cancer
25. Borderline epithelial lesions of the breast
26. Intraductal epithelial proliferation in the human breast: A comparative study
27. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria
28. Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas: European Commission Working Group on Breast Screening Pathology
29. Consistency of histopathologic reporting of breast lesions detected by screening: Findings of the U.K. National External Quality Assessment (EQA) Scheme
30. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: Importance of lesion size and patient age
31. Atypical ductal hyperplasia, atypical lobular hyperplasia, and interpretation of a new borderline lesion